Navigation Links
Pazopanib shows promise in Phase II trial for relapsed/refractory urothelial cancer
Date:10/12/2010

An ongoing Phase-II trial investigating a new, targeted therapy for metastatic urothelial cancer has generated promising early results, Italian researchers reported at the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy.

Urothelial cancers affect the tissue lining the inner surfaces of the bladder and other parts of the urinary system. In cases of metastatic disease, median survival is approximately 12-15 months and there is a 10-15% chance of prolonging it by the use of standard chemotherapy regimens, particularly in otherwise healthy patients with good prognostic factors.

Those whose cancers relapse or do not respond to upfront therapy currently have few second-line treatment options and palliative care is the option in the majority of cases.

Dr Andrea Necchi from Fondazione IRCCS Istituto Nazionale dei Tumori of Milan and colleagues have begun a Phase-II trial using pazopanib in this setting. Pazopanib is a selective inhibitor of several signaling pathways that contribute to tumor growth and the development of new cancer-related blood vessels (angiogenesis).

So far, the researchers have enrolled 18 patients of a total of 41 planned. Each participant had metastatic urothelial cancer that had already failed to respond to at least one prior chemotherapy regimen. This means that investigators treated many patients who had already failed more than two chemotherapy regimens. Patients were administered 800mg of the drug once daily until their disease progressed or they experienced unacceptable toxicity.

"Thus far, four patients have seen their tumors shrink but, much more interestingly, the great majority of the patients --twelve out of eighteen-- saw their metastases begin to die," Dr Necchi said.

The death of these metastatic tumors, described formally as 'necrotic evolution', was observed by the researchers on monthly computed tomography and positron emission tomography sca
'/>"/>

Contact: Vanessa Pavinato
media@esmo.org
European Society for Medical Oncology
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Phase III study shows everolimus delays tumor progression in hard-to-treat neuroendocrine tumors
2. New Tool Shows Promise for Early Lung Cancer Screening
3. Womens race and class impact contraception recommendations, UCSF study shows
4. Bloodstream infection surveillance inconsistent between institutions, U-M study shows
5. Study shows faith-based interventions can encourage exercise in older African-American women
6. Study shows patient-specific vaccines for metastatic melanoma may induce durable complete regression
7. Unique gastroenterology procedure developed in adults shows promise in pediatrics
8. Novel Rheumatoid Arthritis Drug Shows Early Promise
9. Experimental Drug Shows Promise for Bone Marrow Disorder
10. Report shows federal poverty guidelines leave states seniors destitute
11. Study shows tranquil scenes have positive impact on brain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... Almost three-quarters (74%) of parents are aware ... than one-quarter (28%) have used those online ratings ... according to U-M research published today in ... C.S. Mott Children,s Hospital National Poll on Children,s ... ratings of physicians influenced their choices in seeking ...
(Date:9/22/2014)... Tara Haelle HealthDay Reporter ... how quickly a child,s brain processes sounds might help ... study. Observing children,s brainwaves may also allow ... study authors reported. "The finding that the brain,s ... autism severity is hugely promising," said senior researcher Sophie ...
(Date:9/22/2014)... anxiety, excessive perspiration these symptoms are a few ... the body,s heart rate and plays a crucial role ... from Tel Aviv University points to an additional complication ... published in Mammalian Genome , was conducted by ... the Department of Human Molecular Genetics and Biochemistry at ...
(Date:9/22/2014)... Bethesda, MD (Sept. 22, 2014) The success of ... with poor bowel prep often resulting in missed precancerous ... U.S. Multi-Society Task force on Colorectal Cancer. Additionally, poor ... early repeat procedures. Up to 20 to 25 percent ... bowel preparation. , "When prescribing bowel preparation for ...
(Date:9/22/2014)... (PRWEB) September 22, 2014 Join us for ... 1st Annual “Denim & Pearls Casino Night” Gala. , ... prizes, professional casino games, a raffle, and live and silent ... gala will feature a special buy-in for a Texas Hold’em ... The funds from this event will be used to help ...
Breaking Medicine News(10 mins):Health News:Online ratings influence parents' choices of physicians for their children 2Health News:Brainwaves May Help Gauge Autism Severity: Study 2Health News:Brainwaves May Help Gauge Autism Severity: Study 3Health News:Brainwaves May Help Gauge Autism Severity: Study 4Health News:Lack of thyroid hormone blocks hearing development 2Health News:Good bowel cleansing is key for high-quality colonoscopy 2Health News:Good bowel cleansing is key for high-quality colonoscopy 3Health News:Maverick’s Miracle Babies Foundation Presents the Denim & Pearls Casino Night September 26, 2014 2
... Calif., May 7 As children, we all remember our ... in life, realizing that chewing can help us to appreciate ... presented today to physicians attending the 17th European Congress of ... of Clinical Nutrition reveals that chewing may play a ...
... and CEO of the American Association of Homes and Services ... a plan to finance insurance for long-term services and supports, ... Health Reform conference hosted by the SCAN Foundation and ... Expanding access to the uninsured and restraining the rate of ...
... Retirement Services Division has been selected by Louisiana ... full-service provider for its 401(k) and profit-sharing retirement ... and has more than $10 million in plan ... medical malpractice insurer and is dedicated to developing ...
... Outpatient Procedure to Save Costs Could Put Some Patients ... Decisions LAS VEGAS, May 7 Changes in reimbursement ... more elective percutaneous coronary interventions (PCIs) to "same-day" outpatient ... if they are sent home prematurely, and has left ...
... needs to be curbed, Geriatrics Society says , , ... of non-steroidal anti-inflammatory drugs (NSAIDs) or cox-2 inhibitors ... drastically reduced, according to new pain management guidelines ... (AGS). , The original guidelines recommended the use ...
... With fresh air and wide-open spaces, rural communities ... walking trails, bicycle-friendly streets and gyms tell another story."I ... skate park nearby," said Nikki Ramsey, Kansas State ... services from Statesville, N.C.Although Ramsey,s hometown is small, she ...
Cached Medicine News:Health News:New Almond Study Finds Chewing is More Than Meets the Mouth: Thorough Chewing May Influence Feelings of Fullness 2Health News:New Almond Study Finds Chewing is More Than Meets the Mouth: Thorough Chewing May Influence Feelings of Fullness 3Health News:New Almond Study Finds Chewing is More Than Meets the Mouth: Thorough Chewing May Influence Feelings of Fullness 4Health News:New Almond Study Finds Chewing is More Than Meets the Mouth: Thorough Chewing May Influence Feelings of Fullness 5Health News:AAHSA President Discusses Long-Term Care Solution at SCAN Foundation/Health Affairs Conference 2Health News:MassMutual Chosen as Full-Service Provider for LAMMICO's $10+ Million Retirement Plan 2Health News:SCAI Releases Consensus Statement on Length of Stay Following Elective Percutaneous Coronary Intervention 2Health News:SCAI Releases Consensus Statement on Length of Stay Following Elective Percutaneous Coronary Intervention 3Health News:New Guidelines Recommend Opioids for Seniors' Pain 2Health News:K-State Researchers and Their Partners Making it Easier for Rural Kansans of All Ages to Stay Healthy Despite Limited Access to Facilities Like Bike Trails, Gyms 2
(Date:9/22/2014)... Research and Markets has announced ... Hypercholesterolemia Drugs" report to their offering. ... cholesterol burden despite the presence of many cholesterol-lowering drugs ... statins have been ubiquitously prescribed over the last 25 ... cholesterol (LDLC) is the cornerstone of assessing heart risk. ...
(Date:9/22/2014)... 2014 Persistence Market Research ( ... Study on Ophthalmic Devices: Asia ... market was valued at USD 29,171.5 million in 2014 and ... from 2014 to 2020, to reach an estimated value ... the full Global Market Study on Ophthalmic Devices:  Asia ...
(Date:9/22/2014)... Md. , Sept. 22, 2014  Neuralstem, Inc. (NYSE ... MD, site investigator at Emory University, presented long-term follow ... human neural stem cells in the treatment of amyotrophic ... The presentation, which occurred at the Annual Symposium on ... Canada , on Friday, and was not open ...
Breaking Medicine Technology:PCSK9 and Other Novel Hypercholesterolemia Drugs 2PCSK9 and Other Novel Hypercholesterolemia Drugs 3Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 2Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 3Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 4Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 5Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data 2Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data 3Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data 4
... 14, 2011 /PRNewswire-Asia-FirstCall/ -- China Botanic Pharmaceutical Inc. ... Inc.) ("China Botanic" or the "Company"), a developer, ... traditional Chinese medicines ("TCM") in China, today announced ... Enterprise assessment, and that as a result, China ...
... 14, 2011 Reportlinker.com announces that a new ... Global Cardiac Monitoring Systems Market ... With advancements in technology, innovative product offerings ... introduced in the Cardiac Monitoring Systems market. Further, ...
Cached Medicine Technology:China Botanic Pharmaceutical Receives a Tax Exemption in 2011 2China Botanic Pharmaceutical Receives a Tax Exemption in 2011 3Reportlinker Adds Global Cardiac Monitoring Systems Market -2013 2Reportlinker Adds Global Cardiac Monitoring Systems Market -2013 3
... Plate Shaker are designed to give reliable performance ... microplates. The on/off button, power supply socket and ... of the unit. The speed knob is located ... of speed from a minimum 950 rpm to ...
... FACSCalibur is the only four-color, automated benchtop ... analysis and cell sorting. Designed specifically to ... FACSCalibur system offers software instrument control, auto-sample ... ease and productivity. FACSCalibur is fully modular ...
... Compact mobile flow cytometer for ... absolute volumetric counting. The CyFlow SL ... in combination with up to 3 ... real-time display is performed with a ...
The Elecsys 2010 Rack System streamlines processes and allows for smooth implementation of laboratory automation....
Medicine Products: